Loading...
Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume
We retrospectively investigated outcomes, including pulmonary toxicities, of stereotactic body radiation therapy using RapidArc and a risk-adapted 60% isodose plan for early-stage non-small-cell lung cancer patients. We evaluated patients staged as cT1a–2bN0M0 between 2011 and 2017 and treated with...
Na minha lista:
| Udgivet i: | J Radiat Res |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6530627/ https://ncbi.nlm.nih.gov/pubmed/30668868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jrr/rry112 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|